Professor Zhiliang Lu is a recipient of the Leading Sci-Edu Talents of the SIP Jinji Lake Double Hundred Talents. Following an undergraduate study in Pharmaceutical Sciences, he pursued an MSc in Pharmacology both at Zhejiang University. He then obtained his PhD degree in Shanghai Jiaotong University School of Medicine in1990 where he started to work on G protein-coupled receptors (GPCRs), major cell surface drug targets. Following his appointment to a Lecturer (1991-1992) and an Associate Professor (1992-1995) at the Department of Biological Sciences and Technology, Zhejiang University, he rapidly established his own research lab focusing on the structure-function relationships of GPCRs and their cell signalling. He is a supervisor of MRes and PhD students. His research was well funded by national grants such as National Science Foundation of China (NSFC). Professor Lu was awarded a Wellcome Trust Postdoctoral Fellowship (1995-1997) at the Medical Research Council (MRC) National Institute for Medical Research (NIMR, now Francis Crick Institute). He was then awarded an MRC appointment as a Band 3 senior scientist (1997-2001), where he retained his research interest on GPCRs. Following his research success at NIMR, he was offered an MRC Programme Leader Track position (2001-2007) at MRC Human Reproductive Sciences Unit in the University of Edinburgh, and was then promoted to the Tenured Programme Leader in 2007. Professor Lu continues his research on GPCRs and cell signalling in neurons, reproduction, metablism  and cancers funded by NSFC and XJTLU research development funds after he joined XJTLU in 2011. He is also interested in cell signaling control of mRNA methylation in pathophysiology. Professor Lu has authored or co-authored more than 100 peer-reviewed journal and conference publications and book chapters. He is an honorary Professor and PhD supervisor of the University of Liverpool.

Ligand-induced selective signalling of GPCRs in neurons, metablism and cancer.

Gene and cell control of mRNA methylation in carcinogenesis.

Development and application of the state-of-art NanoBRET technology in protein-protein interaction and high throughput drug screening.

Director of Suzhou Municipal Key Lab of Cancer Biology and Chronic Disease (2024-)

Research Director of School of Science, XJTLU (2021-22)

Professor of the Department of Biosciences and Bioinfromatics, XJTLU, 2011-

Tenured Programme Leader, MRC HRSU, Edinburgh University, 2007 – 2011.

Programme Leader Track, MRC, HRSU, Edinburgh University, 2001 – 2007.

Senior Scientist, MRC National Institute for Medical Research, 1997 - 2001

Wellcome Trust Postdoctoral Fellowship, MRC NIMR, 1995 – 1997.

Associate Professor, Department of Biological Sciences and Technology, Zhejiang University, 1992-1995.

Lecturer, Deaprtment of Biological Sciences and Technology, Zhejiang University, 1991 – 1992.

BIO301 Biology of Disease (Biochemistry of Disease and Cancer Biology, Year 4), 2011-present.

BIO208 Cell Signalling (Year 3), 2011-present.

BIO303 Final Year Project (Year4), Coordinator, 2011-2013 and 2014-2018.

BIO302 Biochemical Messengers (Year 4), 2011-2017.

BIO111 Key Skills for Life Scientists (Year 2), 2011-13.

2011 Jinji Lake 200 Talent Programme, Suzhou Industrial Park

1994 Excellent Young Teacher, Zhejiang University

1993 Yilida Excellent Teacher, Zhejiang University

1993 Supervisor of PhD students, Zhejiang University

1992 Excellent paper, The Science and Technology Association of Zhejiang Province

1992 Excellent Award in Science & Technology, Zhejiang University